Primary Record
Erismodegib
- In stock
- 5,404 g
- Purity
- 99.3 %
- CAS
- 956697-53-3
Compound Identifiers & Properties
- CAS
- 956697-53-3
- PubChem CID
- 24775005
- SMILES
- C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F
- Canonical SMILES
- Cc1c(C(=O)Nc2ccc(N3C[C@@H](C)O[C@@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1
Names & Synonyms
- Erismodegib
- Sonidegib
- LDE225
- Odomzo
- NVP-LDE225
- 956697-53-3
- Odomozo
- sonidegibum
- NVP-LDE 225
- Sonidegib phospate
- LDE-225
- Sonidegib phosphate
- LDE 225
- Erismodegib [INN]
- sonidegib diphosphate
- 0RLU3VTK5M
- Erismodegib [USAN]
- Sonidegib (LDE-225)
- LDE225 Diphosphate
- Sonidegib [USAN:INN]
- UNII-0RLU3VTK5M
- Erismodegib [USAN:INN]
- RefChem:56755
- SONIDEGIB [INN]
- NVP-LDE-225
- SONIDEGIB [MI]
- Sonidegib (USAN/INN)
- SONIDEGIB [USAN]
- erismodegib (deleted INN)
- cc-76
- D09BNZ
- SONIDEGIB [WHO-DD]
- LDE225 (NVP-LDE225,Erismodegib)
- MFCD16038928
- Sonidegib (NVP-LDE225)
- CHEBI:90863
- MLS006011198
- NPV-LDE-225
- NVP-LDE225(Erismodegib)?
- SCHEMBL554455
- C26H26F3N3O3
- Smoothened Antagonist LDE225
- VZZJRYRQSPEMTK-CALCHBBNSA-N
- DTXSID501009335
- GTPL8199
- orb1307090
- CHEMBL2105737
- NVP-LDE225/LDE225
- 956697-53-3 (free base)
- EX-A409
- L01XX48
- NVP-L DE 225
- LDE225(NVP-LDE225)
- DTXCID101436164
- GLXC-90320
- BCP02275
- KS-00000TD3
- LDE 225, NVP-LDE225
- LDE225 (NVP-LDE225)
- LDE225 - NVP-LDE225
- ABP000896
- BDBM50394562
- EBC-11443
- HY-16582A
- LDE225 (NVP-LDE225; Erismodegib)
- NSC761385
- NSC761386
- s2151
- ZINC68202099
- Sonidegib;LDE225; NVP-LDE 225
- AKOS015994541
- ACN-036618
- BCP9001014
- C26-H26-F3-N3-O3
- CCG-264935
- CS-0904
- DB09143
- EE-0005
- FE22786
- NSC-761385
- NSC-761386
- LDE225 (NVP-LDE225, Erismodegib)
- NCGC00250382-01
- NCGC00250382-05
- NCGC00250382-07
- NCGC00250382-19
- 4CA-0728
- AC-32799
- BP-44050
- CID:24775005
- HY-10296
- SC-85832
- SMR004702967
- SID:254561544
- B2266
- NS00072903
- SW218115-2
- X7564
- J3.351.814E
- A10520
- A25438
- D10119
- W-5625
- 956697-53-3, NVP-LDE225
- EN300-7362818
- C561435
- rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
- BRD-K19796430-001-01-5
- BRD-K19796430-001-05-6
- BRD-K19796430-001-09-8
- Q22075856
- N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide
- N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide
- N-(6-(cis-2,6-Dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
- Z2588040168
- B0084-286449
- N-(6-((2R,6S)-2,6-Dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide
- N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
- (1,1'-Biphenyl)-3-carboxamide, N-(6-((2R,6S)-2,6-dimethyl-4-morpholinyl)-3-pyridinyl)-2- methyl-4'-(trifluoromethoxy)-, rel-
- (1,1'-BIPHENYL)-3-CARBOXAMIDE, N-(6-((2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL)-3-PYRIDINYL)-2-METHYL-4'-(TRIFLUOROMETHOXY)-, REL-
- [1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(t
- 1218778-77-8
- N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
- n-(6-((2r,6s)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide
- N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
- N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-3-pyridyl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
- N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
- [1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-, rel-
- [1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-, rel-; rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide; LDE 225; NVP-LDE 225; Odomzo; Sonidegib
- 1,1'-Biphenyl)-3-carboxamide, N-(6-((2R,6S)-2,6-dimethyl-4-morpholinyl)-3-pyridinyl)-2- methyl-4'-(trifluoromethoxy)-, rel-
- 1218778-76-7
- 881-485-3
- Erismodegib|||LDE 225|||NVP-LDE 225|||N-[6-[(2S,6R)-2,6-Dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
- N-(6-((2R,6S)-2,6-Dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'- (trifluoromethoxy)biphenyl-3-carboxamide
- N-(6-((2R,6S)-2,6-dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-(1,1'-biphenyl)-3-carboxamide
- N-(6-((2S,6R)-2,6-dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide
- N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
- N-(6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)(1,1'-biphenyl)-3-carboxamide
- N-(6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl)-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
- N-[6-(2alpha,6alpha-Dimethylmorpholino)-3-pyridyl]-2-methyl-4 -(trifluoromethoxy)-1,1 -biphenyl-3-carboxamide
- N-[6-(cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy) [1,1'- biphenyl]-3-carboxamide
- N-[6-[(2R,6S)-2,6-Dimethyl-4-morphlinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
- N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
- N-{6-[(2R,6S)-2,6-Dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
- rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-1,1'-biphenyl]-3-carboxamide
- rel-N-{6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide